pirenzepine has been researched along with Neutropenia in 6 studies
Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.
Excerpt | Relevance | Reference |
---|---|---|
"Olanzapine is a new antipsychotic drug, pharmacodynamically similar to clozapine, but putatively devoid of haematological iatrogenicity." | 5.30 | Olanzapine-induced neutropenia after clozapine-induced neutropenia. ( Benedetti, F; Cavallaro, R; Smeraldi, E, 1999) |
"Olanzapine is a tricyclic neuroleptic agent that due to structural similarities was expected to be a safe alternative to clozapine, which has a 0." | 5.30 | Two cases of olanzapine-induced reversible neutropenia. ( Grohmann, R; Pedrosa, F; Rüther, E; Schwerdtner, I; Steinwachs, A, 1999) |
"We report a 2-year experience with olanzapine treatment (20 mg daily) in a 65-year-old male patient with treatment-resistant paranoid schizophrenia, who had previously developed leucopenia and neutropenia first on clozapine and, subsequently, also on risperidone." | 3.70 | Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone. ( Dernovsek, MZ; Tavcar, R, 2000) |
"Olanzapine is a new antipsychotic drug, pharmacodynamically similar to clozapine, but putatively devoid of haematological iatrogenicity." | 1.30 | Olanzapine-induced neutropenia after clozapine-induced neutropenia. ( Benedetti, F; Cavallaro, R; Smeraldi, E, 1999) |
"Olanzapine is a tricyclic neuroleptic agent that due to structural similarities was expected to be a safe alternative to clozapine, which has a 0." | 1.30 | Two cases of olanzapine-induced reversible neutropenia. ( Grohmann, R; Pedrosa, F; Rüther, E; Schwerdtner, I; Steinwachs, A, 1999) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benedetti, F | 1 |
Cavallaro, R | 1 |
Smeraldi, E | 1 |
Steinwachs, A | 1 |
Grohmann, R | 1 |
Pedrosa, F | 1 |
Rüther, E | 1 |
Schwerdtner, I | 1 |
Dernovsek, MZ | 1 |
Tavcar, R | 1 |
Gram, LF | 1 |
Teter, CJ | 1 |
Early, JJ | 1 |
Frachtling, RJ | 1 |
Hong, X | 1 |
Wang, X | 1 |
6 other studies available for pirenzepine and Neutropenia
Article | Year |
---|---|
Olanzapine-induced neutropenia after clozapine-induced neutropenia.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Neutropenia; Olanzapine; Pi | 1999 |
Two cases of olanzapine-induced reversible neutropenia.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Female; Humans; Male; Neutrop | 1999 |
Olanzapine appears haematologically safe in patients who developed blood dyscrasia on clozapine and risperidone.
Topics: Aged; Antipsychotic Agents; Benzodiazepines; Clozapine; Drug Monitoring; Humans; Leukopenia; Male; N | 2000 |
[Is bone marrow inhibition a special risk in connection with olanzapine (Zyprexa) treatment?].
Topics: Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Bone Marrow; Female; Humans; Leukocyte Cou | 2000 |
Olanzapine-induced neutropenia in patients with history of clozapine treatment: two case reports from a state psychiatric institution.
Topics: Antipsychotic Agents; Benzodiazepines; Clozapine; Dose-Response Relationship, Drug; Drug Administrat | 2000 |
Agranulocytosis and neutropenia with typical and atypical neuroleptics.
Topics: Adult; Agranulocytosis; Antipsychotic Agents; Benzodiazepines; Clozapine; Female; Humans; Leukocyte | 2001 |